Systemic inflammation, which increases levels of CRP [7], stimulates pathological arterial intimal changes which are part of the basis for later CVD, while insulin resistance forms the key pathological change leading to T2DM. The gene discussed is CRP; the disease is type 2 diabetes mellitus.